10Lun·

$GILD (+1,02 %) Gilead Science

This is now my tenth title in the healthcare sector


Market cap € 85 bn

P/E ratio approx. 13

Continuous increase in dividends

Double-digit profit growth with constant sales

Solidly filled pipeline (https://www.gilead.com/science-and-medicine/pipeline)

and ongoing acquisitions


Buy and hold, or add more if the share price weakens.

16.02
Gilead Sciences logo
Compró 50 a 71,92 US$
3595,98 US$
8
Únase a la conversación